Amaris Elliott Engel

September 16, 2014 | National Law Journal

A plaintiffs expert in the multidistrict litigation over the Chantix antismoking drug has moved to unseal court records in the advance of a U.S. Food and Drug Administration meeting next month to consider whether warnings about suicide risk are warranted.

By Amaris Elliott-Engel

3 minute read

September 16, 2014 | National Law Journal

The comment period closed Monday regarding best practices for developing proprietary names for drugs to avoid medical errors, with a number of pharmaceutical companies weighing in with the U.S. Food and Drug Administration.

By Amaris Elliott-Engel

2 minute read

September 12, 2014 | National Law Journal

A consumer rights advocacy group has lost a Freedom of Information Act fight to access the compliance records Pfizer Inc. and Purdue Pharma LP filed with the government as part of their settlement of health care fraud cases.

By Amaris Elliott-Engel

2 minute read

September 12, 2014 | National Law Journal

U.S. Magistrate Judge James C. Francis IV, who has been appointed as the master to administer a $27.7 million settlement fund over Merck Sharpe & Dohme Corp.'s Fosamax, has set up the process for plaintiffs to appeal their settlement allocations.


By Amaris Elliott-Engel

2 minute read

September 12, 2014 | National Law Journal

The U.S. Court of Appeals for the Seventh Circuit has struck down a $180 million verdict in favor of three workers injured by a grain bin that exploded at a flour mill.

By Amaris Elliott-Engel

3 minute read

September 12, 2014 | National Law Journal

Vermont's recently enacted law requiring genetically engineered foods to be labeled by food manufacturers has come under attack by a coalition of trade association groups for the food industry.

By Amaris Elliott-Engel

2 minute read

September 12, 2014 | National Law Journal

A group of law firms representing plaintiffs claiming that exposure to Garlock Sealing Technologies LLC's products caused their asbestos-related illnesses want medical records and information about their settlements sealed in Garlock's bankruptcy.

By Amaris Elliott-Engel

3 minute read

September 12, 2014 | Connecticut Law Tribune

One lawyer's foray into a class action over public housing in New London started with a slip-and-fall case and ended with an unusual settlement that will see a Superior Court judge overseeing apartment complex renovations.

By Amaris Elliott-Engel

6 minute read

September 10, 2014 | National Law Journal

The city of Chicago has come out swinging against Purdue Pharma L.P.'s motion to disqualify the city's lead lawyer in a lawsuit over opioid painkillers.

By Amaris Elliott-Engel

2 minute read

September 10, 2014 | National Law Journal

The Kellogg Company has gotten out of a class action alleging that consumers of Kashi Company's “natural” food products were deceived because the products contain genetically modified organisms and synthetic ingredients like GMO soy, soy derivatives and corn derivatives.

By Amaris Elliott-Engel

3 minute read